Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers–Danlos syndrome
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The sulfated polysaccharide dermatan sulfate (DS) forms proteoglycans with a number of distinct core proteins. Iduronic acid-containing domains in DS have a key role in mediating the functions of DS proteoglycans. Two tissue-specific DS epimerases, encoded by DSE and DSEL, and a GalNAc-4-O-sulfotransferase encoded by CHST14 are necessary for the formation of these domains. CHST14 mutations were previously identified for patients with the musculocontractural type of Ehlers-Danlos syndrome (MCEDS). We now identified a homozygous DSE missense mutation (c.803C>T, p.S268L) by the positional candidate approach in a male child with MCEDS, who was born to consanguineous parents. Heterologous expression of mutant full-length and soluble recombinant DSE proteins showed a loss of activity towards partially desulfated DS. Patient-derived fibroblasts also showed a significant reduction in epimerase activity. The amount of DS disaccharides was markedly decreased in the conditioned medium and the cell fraction from cultured fibroblasts of the patient when compared with a healthy control subject, whereas no apparent difference was observed in the chondroitin sulfate (CS) chains from the conditioned media. However, the total amount of CS disaccharides in the cell fraction from the patient was increased ∼1.5-fold, indicating an increased synthesis or a reduced conversion of CS chains in the cell fraction. Stable transfection of patient fibroblasts with a DSE expression vector increased the amount of secreted DS disaccharides. DSE deficiency represents a specific defect of DS biosynthesis. We demonstrate locus heterogeneity in MCEDS and provide evidence for the importance of DS in human development and extracellular matrix maintenance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“No difference was seen in CS chains from the conditioned media, though the total amount of CS disaccharides in the cell fraction from the patient was increased approximately 1.5-fold, consistent with increased synthesis or reduced conversion of CS chains”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as M€ uller et al., 2013
In the citing paper
“Heterologous expression of mutant full-length and soluble recombinant DSE proteins harboring the p.(Ser268Leu) substitution showed a loss of activity towards partially desulfated DS, and patient-derived fibroblasts also showed a significant reduction in epimerase activity.”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as M€ uller et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heparan sulphate proteoglycans fine-tune mammalian physiology
Bishop, J. R., Schuksz, M., & Esko, J. D. (2007) · Nature · doi:10.1038/nature05817 · Cited by 1,631
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate
Sugahara, K., Mikami, T., Uyama, T., Mizuguchi, S., Nomura, K., & Kitagawa, H. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.09.011 · Cited by 694
Self-citationThe Ehlers–Danlos syndrome, a disorder with many faces
De Paepe, A., & Malfait, F. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01858.x · Cited by 379 · cited 1×
“However, the recent identification of new EDS genes would justify a revision of the Villefranche classification (25).”
BackgroundTenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366 · cited 1×
“The phenotypic overlap of MCEDS and the tenascin-X (TNX [MIM 600985])-deficient form of EDS (MIM 606408) (64) might be caused by a disruption of extracellular binding of decorin and tenascin-X, which also binds to tropoelastin and collagen types I, III, V, XII and XIV (65,66).”
BackgroundQuentin, E., Gladen, A., Rodén, L., & Kresse, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1342 · Cited by 187
Baumann, M., Giunta, C., Krabichler, B., Rüschendorf, F., Zoppi, N., Colombi, M., Bittner, R. E., Quijano-Roy, S., Muntoni, F., Cirak, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.004 · Cited by 162
Self-citationMolecular Basis for the Progeroid Variant of Ehlers-Danlos Syndrome
Okajima, T., Fukumoto, S., Furukawa, K., Urano, T., & Furukawa, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28841 · Cited by 157
Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome
Miyake, N., Kosho, T., Mizumoto, S., Furuichi, T., Hatamochi, A., Nagashima, Y., Arai, E., Takahashi, K., Kawamura, R., Wakui, K., et al. (2010) · Human Mutation · doi:10.1002/humu.21300 · Cited by 156 · cited 7×
“We recently described loss-of-function mutations in CHST14, resulting in dermatan 4-O-sulfotransferase 1 (D4ST1) deficiency, as the first disorder resulting from impaired DS biosynthesis (26,27).”
BackgroundSelf-citationMalfait, F., Syx, D., Vlummens, P., Symoens, S., Nampoothiri, S., Hermanns-Lê, T., Van Laer, L., & De Paepe, A. (2010) · Human Mutation · doi:10.1002/humu.21355 · Cited by 122
Evers, M. R., Xia, G., Kang, H.-G., Schachner, M., & Baenziger, J. U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105848200 · Cited by 117 · cited 2×
“Apparently, DSELcannotcompensate for the lossof DSE function, analogous to the situation where CS 4-O-sulfotransferases cannot compensate for the lossof D4ST1, and in linewith reported invitro substrate specificities of human sulfotransferases involved in the 4-O-sulfation of CS/DS (20,21).”
BackgroundKosho, T., Miyake, N., Hatamochi, A., Takahashi, J., Kato, H., Miyahara, T., Igawa, Y., Yasui, H., Ishida, T., Ono, K., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33498 · Cited by 88 · cited 1×
“Adducted thumb-clubfoot syndrome (ATCS) (26,29–31), Kosho Type of EDS (27,32,33), Dündar syndrome, as well as kyphoscoliosis EDS without lysyl hydroxylase deficiency (EDS VIB) and distal arthrogryposis with peculiar facies and hydronephrosis are terms that have been used to describe this disorder.”
BackgroundA model of tenascin-X integration within the collagenous network
Lethias, C., Carisey, A., Comte, J., Cluzel, C., & Exposito, J.-Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.037 · Cited by 74
Shimizu, K., Okamoto, N., Miyake, N., Taira, K., Sato, Y., Matsuda, K., Akimaru, N., Ohashi, H., Wakui, K., Fukushima, Y., et al. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34115 · Cited by 68 · cited 1×
“In contrast to D4ST1 deficiency, where ecchymoses and hematoma formation are common (37), this was not observed in our young patient with DSE deficiency so far.”
BackgroundKosho, T., Takahashi, J., Ohashi, H., Nishimura, G., Kato, H., & Fukushima, Y. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30965 · Cited by 51
Voermans, N. C., Kempers, M., Lammens, M., van Alfen, N., Janssen, M. C., Bönnemann, C., van Engelen, B. G., & Hamel, B. C. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35232 · Cited by 36 · cited 2×
“MCEDS also affects muscles to a variable degree (38).”
BackgroundJanecke, A. R., Baenziger, J. U., Müller, T., & Dündar, M. (2011) · Human Mutation · doi:10.1002/humu.21440 · Cited by 18
Self-citation
Cited by
Malfait, F., Castori, M., Francomano, C. A., Giunta, C., Kosho, T., & Byers, P. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0194-9 · Cited by 316
The Ehlers–Danlos syndromes, rare types
Brady, A. F., Demirdas, S., Fournel‐Gigleux, S., Ghali, N., Giunta, C., Kapferer‐Seebacher, I., Kosho, T., Mendoza‐Londono, R., Pope, M. F., Rohrbach, M., et al. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31550 · Cited by 258
Self-citationFrom Structure to Phenotype: Impact of Collagen Alterations on Human Health
Arseni, L., Lombardi, A., & Orioli, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051407 · Cited by 186
“EDSMC1 and 2 share most of the clinical features, even though the majority of cases (31) refer to the EDSMC1 and only three cases are reported for the EDSMC2 type [78].”
BackgroundColombi, M., Dordoni, C., Chiarelli, N., & Ritelli, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31429 · Cited by 127
Vascular aspects of the Ehlers-Danlos Syndromes
Malfait, F. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.013 · Cited by 113
Metadata
- Authors
- Müller, T., Mizumoto, S., Suresh, I., Komatsu, Y., Vodopiutz, J., Dundar, M., Straub, V., Lingenhel, A., Melmer, A., Lechner, S., Zschocke, J., Sugahara, K., & Janecke, A. R.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-23
- Volume
- 22
- Issue
- 18
- Pages
- 3761-3772
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2138283511
- Cited by
- 104
- References
- 16
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.